Alignment Healthcare, Inc. 8-K

What Happened

• Alignment Healthcare, Inc. filed an 8-K on June 9, 2026 reporting the results of its virtual Annual Meeting held June 4, 2026. A total of 194,112,992 shares of common stock were represented.
• Three Class II directors were elected to three-year terms (until the 2029 annual meeting): Jody Bilney, David Hodgson, and Jacqueline Kosecoff. The meeting also ratified Deloitte & Touche LLP as the independent auditor for fiscal 2026 and approved, on an advisory basis, the company’s executive compensation (say-on-pay).

Key Details

• Shares represented at the meeting: 194,112,992.
• Director vote totals:
  • Jody Bilney — For: 135,714,231; Withhold: 42,598,200; Broker Non-Vote: 15,800,560.
  • David Hodgson — For: 108,386,550; Withhold: 69,925,881; Broker Non-Vote: 15,800,560.
  • Jacqueline Kosecoff — For: 135,613,817; Withhold: 42,698,614; Broker Non-Vote: 15,800,560.
• Auditor ratification (Deloitte & Touche LLP): For 194,030,577; Against 13,893; Abstain 68,522.
• Advisory say-on-pay vote: For 169,068,300; Against 8,701,941; Abstain 542,191; Broker Non-Vote 15,800,560.

Why It Matters

• Board continuity: election of the three Class II directors maintains the company’s governance team through 2029, which can affect strategic direction and oversight.
• Audit continuity: ratifying Deloitte ensures the company’s independent audit firm is in place for fiscal 2026, which matters for financial reporting and investor confidence.
• Executive pay approval: the advisory say-on-pay received majority support, indicating shareholder approval of the company’s executive compensation practices as presented at the meeting.